This inventor holds 4 USPTO granted patents. Top assignee: Wyeth. Active years: 2004-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2008
Title: Innovations by Lee Erwin Schechter
Introduction
Lee Erwin Schechter is a notable inventor based in Toms River, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of serotonergic agents. With a total of 4 patents to his name, Schechter's work focuses on addressing sexual dysfunction and mental health issues.
Latest Patents
One of his latest patents is titled "Serotonergic agents for treating sexual dysfunction." This patent provides methods and compositions for treating sexual dysfunction, particularly that associated with drug treatment, using 5-HT receptor antagonists. Another significant patent is "Bicyclic indolyl derivatives and methods for their use as serotonergic agents." This patent discloses bicyclic indolyl derivatives and compositions containing such compounds. It also outlines methods for using these derivatives as serotonergic agents in the treatment of depression and anxiety, along with processes for their preparation.
Career Highlights
Lee Erwin Schechter is currently associated with Wyeth, a prominent pharmaceutical company. His work at Wyeth has allowed him to focus on innovative solutions in the treatment of various health conditions. His contributions have been instrumental in advancing the understanding and treatment of sexual dysfunction and mental health disorders.
Collaborations
Some of his notable coworkers include Wayne Everett Childers and Michael G Kelly. Their collaborative efforts have further enhanced the research and development of serotonergic agents.
Conclusion
Lee Erwin Schechter's innovative work in the field of pharmacology has led to significant advancements in the treatment of sexual dysfunction and mental health issues. His patents reflect a commitment to improving patient outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
